{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:10:29Z","timestamp":1781104229819,"version":"3.54.1"},"reference-count":13,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1297\/cpe.17.71","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T01:51:46Z","timestamp":1218160306000},"page":"71-74","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: Adjuvant Therapy with a High Dose of Mitotane for Adrenocortical Carcinoma in a 4-year-old Boy"],"prefix":"10.1297","volume":"17","author":[{"given":"Takako","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Miyako","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"},{"name":"Present: Department of Pediatrics, Beppu Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Kuromaru","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Torisu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Sanefuji","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Nagamatsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ciftci AO, Senocak ME, Tanyel FC, Buyukpamukcu N. Adrenocortical tumors in children. J Pediatr Surg 2001;36:549-54.","DOI":"10.1053\/jpsu.2001.22280"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004;22:838-45.","DOI":"10.1200\/JCO.2004.08.085"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Teinturier C, Pauchard MS, Brugieres L, Landais P, Chaussain JL, Bougneres PF. Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 1999;32:106-11.","DOI":"10.1002\/(SICI)1096-911X(199902)32:2<106::AID-MPO7>3.0.CO;2-J"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van Slooten H, Moolenaar AJ, van Seters AP, Smeenk D. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring. Eur J Cancer Clin Oncol 1984;20:47-53.","DOI":"10.1016\/0277-5379(84)90033-6"},{"issue":"5","key":"5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.1994.183","volume":"69","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0007-0920","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baudin E, Pellegriti G, Bonnay M, Penfornis A, Laplanche A, Vassal G, et al. Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer 2001;92:1385-92.","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bollen E, Lanser JB. Reversible mental deterioration and neurological disturbances with o,p'-DDD therapy. Clin Neurol Neurosurg 1992;94(Suppl):S49-51.","DOI":"10.1016\/0303-8467(92)90020-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007;356:2372-80.","DOI":"10.1056\/NEJMoa063360"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yonemoto T, Tatezaki S, Ishii T, Hagiwara Y, Inoue M. Multiple primary cancers in patients with osteosarcoma: influence of anticancer drugs and genetic factors. Am J Clin Oncol 2004;27:220-4.","DOI":"10.1097\/01.COC.0000054534.43117.76"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Krzisnik C, Petric G, Jereb B. Complete response of metastatic adrenal cortical carcinoma to o,p'-DDD in a child. Pediatr Hematol Oncol 1988;5:65-9.","DOI":"10.3109\/08880018809031254"},{"key":"11","unstructured":"11. MOY RH. Studies of the pharmacology of o,p'DDD in man. J Lab Clin Med 1961;58:296-304."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. De Leon DD, Lange BJ, Walterhouse D, Moshang T. Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 2002;87:4452-6.","DOI":"10.1210\/jc.2001-011978"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nagasaki K, Horikawa R, Nagaishi J, Honna T, Sekiguchi A, Tsunematsu Y, et al. Virilizing adrenocortical carcinoma invading the right atrium with histological high-grade malignancy and p53 mutation in a 3-year-old child: indication of post operative adjuvant chemotherapy. Clin Pediatr Endocrinol 2004;13:25-32.","DOI":"10.1297\/cpe.13.25"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/cpe\/17\/3\/17_3_71\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T22:19:42Z","timestamp":1617142782000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/cpe\/17\/3\/17_3_71\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.17.71","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}